Literature DB >> 17107743

Chitooligosaccharides in combination with interferon-gamma increase nitric oxide production via nuclear factor-kappaB activation in murine RAW264.7 macrophages.

Guan James Wu1, Guo Jane Tsai.   

Abstract

A low-molecular weight chitosan (LMWC) with a molecular mass of 20 kDa and a chitooligosaccharide mixture (oligomixture) which is composed of sugars with a degree of polymerization (DP) of 1-6 were isolated from the chitosan hydrolysate. The effects of the chitosan hydrolysate, LMWC and oligomixture on the production of nitric oxide (NO) in RAW 264.7 macrophages were evaluated, and their effects on NF-kappaB activation and the gene expression of inducible NO synthase (iNOS) were further investigated. None of the tested 3 samples of hydrolysate, LMWC and oligomixture alone affected the NO production in RAW 264.7 macrophages. However, treatment of macrophages with a combination of hydrolysate/oligomixture and interferon-gamma (IFN-gamma) significantly induced NO production in a dose-dependent manner, whereas a combination of LMWC and IFN-gamma inhibited NO production. These effects on NO synthesis were evidenced via regulating the iNOS gene expression. Both hydrolysate and oligomixture promoted the migration of NF-kappaB into the nucleus and enhanced its DNA binding activity. MG132, a specific inhibitor of NF-kappaB, eliminated the NO synthesis in IFN-gamma plus hydrolysate/oligomixture-induced RAW264.7 macrophages. The treatment of RAW264.7 macrophages with anti-CD14, anti-TLR4, and anti-CR3 antibodies significantly blocked NO production induced by IFN-gamma plus hydrolysate/oligomixture. These results demonstrated that the oligomixture, which is the main functional component in the chitosan hydrolysate, in combination with IFN-gamma, synergistically induced NF-kappaB activation and NO production through binding with the receptors of CD14, TLR4 and CR3 in RAW264.7 macrophages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17107743     DOI: 10.1016/j.fct.2006.07.025

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  10 in total

1.  Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases.

Authors:  Hong-tao Liu; Pei Huang; Pan Ma; Qi-shun Liu; Chao Yu; Yu-guang Du
Journal:  Acta Pharmacol Sin       Date:  2011-04       Impact factor: 6.150

2.  Novel β-N-acetylglucosaminidases from Vibrio harveyi 650: cloning, expression, enzymatic properties, and subsite identification.

Authors:  Wipa Suginta; Duangkamon Chuenark; Mamiko Mizuhara; Tamo Fukamizo
Journal:  BMC Biochem       Date:  2010-09-29       Impact factor: 4.059

Review 3.  Keeping track of the growing number of biological functions of chitin and its interaction partners in biomedical research.

Authors:  Bjørn E V Koch; Jens Stougaard; Herman P Spaink
Journal:  Glycobiology       Date:  2015-01-16       Impact factor: 4.313

4.  Immunostimulative Activity of Low Molecular Weight Chitosans in RAW264.7 Macrophages.

Authors:  Ning Wu; Zheng-Shun Wen; Xing-Wei Xiang; Yan-Na Huang; Yang Gao; You-Le Qu
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

5.  The Positive Correlation of the Enhanced Immune Response to PCV2 Subunit Vaccine by Conjugation of Chitosan Oligosaccharide with the Deacetylation Degree.

Authors:  Guiqiang Zhang; Gong Cheng; Peiyuan Jia; Siming Jiao; Cui Feng; Tao Hu; Hongtao Liu; Yuguang Du
Journal:  Mar Drugs       Date:  2017-07-26       Impact factor: 5.118

6.  Immunomodulatory Effects and Induction of Apoptosis by Different Molecular Weight Chitosan Oligosaccharides in Head Kidney Macrophages From Blunt Snout Bream (Megalobrama amblycephala).

Authors:  Changsong Wu; Yishan Dai; Gailing Yuan; Jianguo Su; Xiaoling Liu
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

7.  Molecular Weight-Dependent Immunostimulative Activity of Low Molecular Weight Chitosan via Regulating NF-κB and AP-1 Signaling Pathways in RAW264.7 Macrophages.

Authors:  Bin Zheng; Zheng-Shun Wen; Yun-Juan Huang; Mei-Sheng Xia; Xing-Wei Xiang; You-Le Qu
Journal:  Mar Drugs       Date:  2016-09-20       Impact factor: 5.118

Review 8.  Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease.

Authors:  Qian-Qian Ouyang; Shannon Zhao; Si-Dong Li; Cai Song
Journal:  Mar Drugs       Date:  2017-11-07       Impact factor: 5.118

Review 9.  Different Macrophage Type Triggering as Target of the Action of Biologically Active Substances from Marine Invertebrates.

Authors:  Lyudmila S Dolmatova; Igor Yu Dolmatov
Journal:  Mar Drugs       Date:  2020-01-02       Impact factor: 5.118

10.  Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility.

Authors:  Sandra Jesus; Ana Patrícia Marques; Alana Duarte; Edna Soares; João Panão Costa; Mariana Colaço; Mélanie Schmutz; Claudia Som; Gerrit Borchard; Peter Wick; Olga Borges
Journal:  Front Bioeng Biotechnol       Date:  2020-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.